Impact of EmbryoGlue as the embryo transfer medium.
Routine use of EmbryoGlue did not significantly improve pregnancy or implantation rates in nonselected patients receiving either a day 3 or day 5 embryo transfer compared with standard culture media. Future prospective randomized studies need to be performed to determine whether EmbryoGlue is beneficial in a selected patient population.
Hazlett
William David
WD
Karande and Associates, S.C., 1585 North Barrington Road, Suite 406, Hoffman Estates, IL 60194, USA. davidhazz@sbcglobal.net
Meyer
Liza R
LR
Nasta
Tricia E
TE
Mangan
Patricia A
PA
Karande
Vishvanath C
VC
D000328:Adult; D003470:Culture Media / Q000494:pharmacology*; D046149:Embryo Culture Techniques; D010064:Embryo Implantation / Q000187:drug effects*; D004624:Embryo Transfer / Q000379:methods*; D004622:Embryo, Mammalian / Q000187:drug effects*; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000494:pharmacology*; D007246:Infertility / Q000503:physiopathology / Q000628:therapy*; D011247:Pregnancy; D018873:Pregnancy Rate; D011446:Prospective Studies; D016037:Single-Blind Method; D013997:Time Factors; D016896:Treatment Outcome
D003470:Culture Media; D006820:Hyaluronic Acid